Stay updated with breaking news from 71404610. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Revvity (NYSE:PKI – Get Rating) in a report issued on Saturday. The firm issued a hold rating on the medical research company’s stock. Other equities research analysts have also recently issued reports about the stock. Credit Suisse Group restated a neutral rating and set a $160.00 price target on […]
Revvity, Inc. (NYSE:PKI – Get Rating) has been given a consensus rating of “Hold” by the twelve analysts that are presently covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among analysts […]
StockNews.com initiated coverage on shares of Revvity (NYSE:PKI – Get Rating) in a research note released on Friday. The brokerage issued a hold rating on the medical research company’s stock. A number of other brokerages have also recently issued reports on PKI. Credit Suisse Group reiterated a neutral rating and set a $160.00 target price […]
PerkinElmer (NYSE:PKI – Get Rating) had its target price lowered by equities research analysts at Citigroup from $170.00 to $160.00 in a report released on Monday, The Fly reports. Citigroup’s price target would indicate a potential upside of 38.84% from the company’s current price. A number of other research firms have also recently issued reports […]
PerkinElmer (NYSE:PKI – Get Rating) had its target price reduced by Barclays from $140.00 to $125.00 in a research report released on Friday morning, The Fly reports. Several other analysts have also weighed in on PKI. Credit Suisse Group restated a neutral rating and set a $160.00 price target on shares of PerkinElmer in a […]